CKD-MBD: from bone biopsy to treatment in advanced CKD patients not vice versa
Sponsors & Exhibitors
ERA organizes the largest annual Nephrology Congress in Europe, welcoming thousands of attendees coming from all over the world, focusing on key learning features both in the clinical field as well as the scientific and latest innovations
Congress Organisation/PCO
Interplan is the appointed PCO for the 60th ERA Congress and the first point of contact with regard to the exhibition and sponsoring related questions.
Congress, Meeting & Event Management AG
Landsberger Str. 155
80687, Munich, Germany
Contacts
Industry Relations Team/Industry Sales & Sponsorship
Sina Ehresmann
era-industry@interplan.de
Exhibition
Sandra Rudolph
era-exhibition@interplan.de
Ethical Med Tech Event – Conference Vetting System
The 60th Congress of the European Renal Association from 15/06/2023 to 18/06/2023 is compliant with the Ethical Med Tech Event – Conference Vetting System with the ID EMT31735.
Disclosure: publication of congress and meeting-related payments
The fees for exhibition space, symposia and other promotional items that have been booked for ERA 2023 will be published provided the sponsor has actively requested this in writing via e.g. the tick-box on the order form, E-Mail/letter or contract. Notification to publish this data must be applied for each individual event/congress. We cannot undertake to assess the possible membership of each company in bodies such as FSA/AKG/EFPIA and hence will not publish the mentioned fees automatically.
FSA rulings or rulings to be considered for CME certification that deviate from this procedure take precedence.
AIFA (Italian Medicines Agency) Congresses and Meeting in Italy
In Italy congresses and meetings on topics related to the use of pharmaceuticals are governed by Article 124 of Legislative Decree 24 April 2006, N 219 (The Decree).
As per Italian law, the AIFA authorization is necessary
- for each pharmaceutical company (with Marketing Authorization Holder or the companies responsible for the actual marketing of pharmaceutical products) sponsoring the congress on topics in any way related to the use of its own pharmaceutical products.
the AIFA authorization is not necessary
- when a company promotes by advertising only medical devices or food supplements during a congress (products without Marketing Authorization)
- when a company sponsors a meeting about topics not related to the use of any of its own medicinal products; in this case the company is not allowed to expose or distribute any kind of advertising material during the meeting (Section 9 art. 124 D.L. n.219/06)
In Italy, any pharmaceutical company that sponsors a congress on topics related to the use of its pharmaceutical products, must submit an application to the competent unit of the Italian Medicines Agency (AIFA) to obtain a specific authorization. If your pharmaceutical company has a marketing authorization (MAH or AIC) in Italy or the companies responsible for the effective marketing of your pharmaceutical products and sponsor the congress on topics related to the use of your pharmaceutical products, you should contact Atlante Viaggi communicating your SIS code, by March 31, 2023: barbara.mantegazza@atlanteviaggi.com
Contacts
Atlante Viaggi Italia Srl
Via Bandello, 1
20123, Milan, Italy
ATLANTE VIAGGI ITALIA has been delegated by ERA 2023 to collect all applications and submit them to AIFA for authorization.